Mini Review Volume 7 Issue 1
Received: May 06, 2020 | Published: May 25, 2020
Citation: Özdemir Ö, Erkun O. Solving puzzle of the immunopathogenesis for management of COVID-19 disease. MOJ Immunol. 2020;7(1):13?15. DOI: 10.15406/moji.2020.07.00258
A novel coronavirus (2019-nCoV) infection was first declared in December 2019 in Wuhan, Hubei Province, China. Coronavirus disease 2019 (COVID-19) is a variation of viral pneumonia, which is happened by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Today, the exact pathogenic mechanism of this viral infection in human remains unclear. COVID-19 is clinically very variable from being asymptomatic, mild to lethal manifestations such as multi-organ failure. There are not currently any specific therapy and/or vaccine for COVID-19 disease management. In this review, we aim to further explore puzzle of the immunopathogenesis in SARS-CoV-2 infection for improving of COVID-19 management.
Keywords: SARS-CoV-2, 2019-nCoV, COVID-19, pathogenesis, management
©2020 Özdemir, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.